Clinical Trial Update: BiPAP in Pediatric Moderate to Severe Asthma Randomized Control Trial [NA]

View source ↗

Summary

A randomized trial evaluating BiPAP in pediatric patients with moderate to severe asthma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• BiPAP

Snippet

Sponsor: University of Colorado, Denver | Conditions: Asthma in Children | NA | Status: TERMINATED